Heimdall Insights

Global Autologous Cell Therapy Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Autologous Cell Therapy Market was valued at $8.5 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 21.5% CAGR, to an estimated market size of $22.5 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The autologous cell therapy market involves medical treatments where a patient's own cells are harvested, processed or genetically modified outside the body, and then re-introduced to treat diseases. This scope includes CAR-T cell therapies, stem cell transplants, and regenerative medicine applications, while excluding allogeneic treatments that use donor cells.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Autologous Cell Therapy Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Oncology
  • Neurodegenerative & Cardiovascular
  • Orthopedic & Other Applications